Chapter 1 Strain Theory of Malaria. The First 50 Years

Advances in Parasitology

Volumn 66, Issue , 2008, Pages 1-46

  McKenzie, F Ellis ^a   Smith, David L ^b   O'Meara, Wendy P ^a   Riley, Eleanor M ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANOPHELES; HUMAN; IMMUNITY; INFECTION RESISTANCE; INFECTION SENSITIVITY; MALARIA; NONHUMAN; PARASITE VIRULENCE; PARASITOSIS; PHENOTYPE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; RELAPSE; REVIEW; SUPERINFECTION; ANIMAL; CLASSIFICATION; DISEASE TRANSMISSION; GENETICS; IMMUNOLOGY; PARASITOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; PLASMODIUM; SPECIES DIFFERENCE; VIRULENCE;

ANTIMALARIAL AGENT; PARASITE ANTIGEN;

ANIMALS; ANOPHELES; ANTIGENS, PROTOZOAN; ANTIMALARIALS; HUMANS; MALARIA; PLASMODIUM; SPECIES SPECIFICITY; VIRULENCE;

EID: 43449088222     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(08)00201-7     Document Type: Review

References (190)

1. A-Elbasit I.E., Elghazali G., A-Elgadir T.M., Hamad A.A., Babiker H.A., Elbashir M.I., and Giha H.A. Allelic polymorphism of MSP2 gene in severe P. falciparum malaria in an area of low and seasonal transmission. Parasitol. Res. 102 (2007) 29-34
2. Anderson T.J., and Roper C. The origins and spread of antimalarial drug resistance: Lessons for policy makers. Acta Trop. 94 (2005) 269-280
3. Arez A.P., Snounou G., Pinto J., Sousa C.A., Modiano D., Ribeiro H., Franco A.S., Alves J., and do Rosario V.E. A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde. Parasitology 118 (1999) 347-355
4. Arnot D. Unstable malaria in Sudan: The influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 580-585
5. Babiker H.A., Ranford-Cartwright L.C., Currie D., Charlwood J.D., Billingsley P., Teuscher T., and Walliker D. Random mating in a natural population of the malaria parasite Plasmodium falciparum. Parasitology 109 (1994) 413-421
6. Babiker H.A., Abdel-Muhsin A.A., Hamad A., Mackinnon M.J., Hill W.G., and Walliker D. Population dynamics of Plasmodium falciparum in an unstable malaria area of eastern Sudan. Parasitology 120 (2000) 105-111
7. Badenski G.T. A Note Describing the Technique Employed in Malariatherapy in the Centres at Rome and Horton (England) (1936), League of Nations Health Organisation Malaria Commission, Geneva (document 237)
8. Barnes K.I., and White N.J. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 94 (2005) 230-240
9. Bejon P., Andrews L., Andersen R.F., Dunachie S., Webster D., Walther M., Gilbert S.C., Peto T., and Hill A.V. Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J. Infect. Dis. 191 (2005) 619-626
10. Bhasin V.K., and Trager W. Gametocyte-forming and non-gametocyte-forming clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33 (1984) 534-537
11. Bishop A. Problems concerned with gametogenesis in Haemosporidiidea, with particular reference to the genus Plasmodium. Parasitology 45 (1955) 163-185
12. Bispham W.N. Malaria (1944), Williams and Wilkins Company, Baltimore
13. Blackburn C.R.B. Observations on the development of resistance to vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 42 (1948) 117-162
14. Boyd M.F. On strains or races of the malaria parasites. Am. J. Trop. Med. 20 (1940) 69-80
15. Boyd M.F. The influence of sporozoite dosage in vivax malaria. Am. J. Trop. Med. 20 (1940) 279-286
16. Boyd M.F. The infection in the intermediate host: Symptomatology, general considerations. In: Moulton F.R. (Ed). A Symposium on Human Malaria (1941), American Association for the Advancement of Science, Washington DC 163-182
17. Boyd M.F. On the varying infectiousness of different patients infected with vivax malaria. Am. J. Trop. Med. 22 (1942) 73-81
18. Boyd M.F. Criteria of immunity and susceptibility in naturally induced vivax malaria infections. Am. J. Trop. Med. 22 (1942) 217-226
19. Boyd M.F. Epidemiology of malaria: Factors related to the intermediate host. In: Boyd M.F. (Ed). Malariology (1949), W. B. Saunders Company, Philadelphia 551-607
20. Boyd M.F., and Kitchen S.F. The comparative susceptibility of Anopheles quadrimaculatus, Say, and Anopheles punctipennis, Say, to Plasmodium vivax, Grassi, and Plasmodium falciparum, Welch. Am. J. Trop. Med. 16 (1936) 67-71
21. Boyd M.F., and Kitchen S.F. On the localization of the geographical distribution of the McCoy strain of Plasmodium vivax. Am. J. Trop. Med. 16 (1936) 583-587
22. Boyd M.F., and Kitchen S.F. Simultaneous inoculation with Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. 17 (1937) 855-861
23. Boyd M.F., and Kitchen S.F. Vernal vivax activity in persons simultaneously inoculated with Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. 18 (1938) 505-514
24. Boyd M.F., and Kitchen S.F. On the heterologous value of acquired immunity to Plasmodium falciparum. J. Natl. Malar. Soc. 4 (1945) 301-306
25. Boyd M.F., and Kitchen S.F. On the homogeneity or heterogeneity of Plasmodium vivax infections acquired in highly endemic regions. Am. J. Trop. Med. 28 (1948) 29-34
26. Boyd M.F., and Stratman-Thomas W.K. Studies on benign tertian malaria 1. On the occurrence of acquired tolerance to Plasmodium vivax. Am. J. Hyg. 17 (1933) 55-59
27. Boyd M.F., and Stratman-Thomas W.K. Studies on benign tertian malaria 3. On the absence of a heterologous tolerance to Plasmodium vivax. Am. J. Hyg. 18 (1933) 482-484
28. Boyd M.F., and Stratman-Thomas W.K. Studies on benign tertian malaria 6. On heterologous tolerance. Am. J. Hyg. 20 (1933) 482-487
29. Boyd M.F., and Stratman-Thomas W.K. The comparative susceptibility of A. quadrimaculatus, Say, and A. crucians, Wied (inland variety) to the parasites of human malaria. Am. J. Hyg. 20 (1934) 247-257
30. Boyd M.F., Stratman-Thomas W.K., and Kitchen S.F. On the relative susceptibility of Anopheles quadrimaculatus to Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. 15 (1935) 485-493
31. Boyd M.F., Stratman-Thomas W.K., and Kitchen S.F. On acquired immunity to Plasmodium falciparum. Am. J. Trop. Med. 16 (1936) 139-145
32. Boyd M.F., Carr H.P., and Rozeboom L.E. On the comparative susceptibility of certain species of Nearctic and Neotropical anophelines to certain strains of P. vivax and P. falciparum from the same regions. Am. J. Trop. Med. 18 (1938) 157-168
33. Boyd M.F., Kupper W.H., and Matthews C.B. A deficient homologous immunity following simultaneous inoculation with two strains of Plasmodium vivax. Am. J. Trop. Med. 18 (1938) 521-524
34. Boyd M.F., Kitchen S.F., and Matthews C.B. On the natural transmission of infection from patients concurrently infected with two strains of Plasmodium vivax. Am. J. Trop. Med. 21 (1941) 645-652
35. Bray R.S., Gunders A.E., Burgess R.W., Freeman J.B., Etzel E., Guttuso C., and Colussa B. The inoculation of semi-immune African with sporozoites of Laverania falcipara (Plasmodium falciparum) in Liberia. Riv. Malariol. 41 (1962) 199-210
36. Bruce-Chwatt L.J. A longitudinal survey of natural malaria infection in a group of West African adults, II. West Afr. Med. J. 12 (1963) 199-217
37. Brumpt E. The human parasites of the genus Plasmodium. In: Boyd M.F. (Ed). Malariology (1949), W. B. Saunders Company, Philadelphia 65-121
38. Bull P.C., Pain A., Ndungu F.M., Kinyanjui S.M., Roberts D.J., Newbold C.I., and Marsh K. Plasmodium falciparum antigenic variation: Relationships between in vivo selection, acquired antibody response, and disease severity. J. Infect. Dis. 192 (2005) 1119-1126
39. Bunker Jr. H.A., and Kirby G.H. Treatment of general paralysis by inoculation with malaria. J. Am. Med. Assoc. 84 (1925) 563-568
40. Burgess R.W., and Young M.D. The comparative susceptibility of Anopheles quadrimaculatus and Anopheles freeborni to infection by Plasmodium vivax (St. Elizabeth strain). J. Natl. Malar. Soc. 9 (1950) 218-221
41. Burkot T.R., Williams J.L., and Schneider I. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Trans. R. Soc. Trop. Med. Hyg. 78 (1984) 339-341
42. Celli A. Malaria (1901), Longmans, Green, and Co., London
43. Chen N., Auliff A., Rieckmann K., Gatton M., and Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195 (2007) 934-941
44. Chernin E. The malariatherapy of neurosyphilis. J. Parasitol. 70 (1984) 611-617
45. Cicero M.T. De Natura Deorum. In: Rackham H. (Ed). Cicero XIX (1933), Harvard University Press, Cambridge, MA transl.), part 3
46. Ciuca M., Ballif L., and Chelarescu-Vieru M. Immunity in malaria. Trans. R. Soc. Trop. Med. Hyg. 27 (1934) 619-622
47. Clyde D.F., and Shute G.T. Resistance of East African varieties of Plasmodium falciparum to pyrimethamine. Trans. R. Soc. Trop. Med. Hyg. 48 (1954) 495-500
48. Clyde D.F., Dawkins Jr. A.T., Heiner G.G., McCarthy V.C., and Hornick R.B. Characteristics of four new drug-resistant strains of Plasmodium falciparum from South-east Asia. Mil. Med. 134 (1969) 787-794
49. Coatney G.R., and Young M.D. The taxonomy of the human malaria parasites with notes on the principal American strains. In: Moulton F.R. (Ed). A Symposium on Human Malaria (1941), American Association for the Advancement of Science, Washington DC 19-24
50. Coatney G.R., Cooper W.C., Ruhe D.S., Young M.D., and Burgess R.W. Studies in human malaria. XVIII. The life pattern of sporozoite-induced St. Elizabeth strain vivax malaria. Am. J. Hyg. 51 (1950) 200-215
51. Coatney G.R., Cooper W.C., and Young M.D. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J. Natl. Malar. Soc. 9 (1950) 381-396
52. Coatney G.R., Collins W.E., Warren McW., and Contacos P.G. The Primate Malarias (1971), U. S. Department of Health Education and Welfare, Washington DC
53. Collins W.E., and Jeffery G.M. A retrospective examination of sporozoite-and trophozoite-induced infections with Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61 (1999) 4-48
54. Collins W.E., Jeffery G.M., and Burgess R.W. Comparative infectivity of strains of P. falciparum to Anopheles quadrimaculatus. Mosq. News 23 (1963) 102-104
55. Contacos P.G., Lunn J.S., and Coatney G.R. Drug-resistant falciparum malaria from Cambodia and Malaya. Trans. R. Soc. Trop. Med. Hyg. 57 (1963) 417-424
56. Contamin H., Fandeur T., Rogier C., Bonnefoy S., Konate L., Trape J.F., and Mercereau-Puijalon O. Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Am. J. Trop. Med. Hyg. 54 (1996) 632-643
57. Cooper W.C., Coatney G.R., Culwell W.B., Eyles D.E., and Young M.D. Studies in human malaria. XXVI. J. Natl. Malar. Soc. 9 (1950) 187-194
58. Craig C.F. Parasitic Protozoa of Man (1926), J. P. Lippincott Company, Philadelphia
59. Davey D.G., and Robertson G.I. Experiments with antimalarial drugs in man II. A description of methods. Trans. R. Soc. Trop. Med. Hyg. 51 (1957) 450-456
60. Day K.P., Karamalis F., Thompson J., Barnes D.A., Peterson C., Brown H., Brown G.V., and Kemp D.J. Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0.3-magabase region of chromosome 9. Proc. Natl. Acad. Sci. USA 90 (1993) 8292-8296
61. de Rudolf G.M. The temperature-chart in artificially-inoculated malaria. J. Trop. Med. Hyg. 27 (1924) 259-263
62. de Rudolf G.M. Therapeutic Malaria (1927), Oxford University Press, London
63. Deaderick W.H. A Practical Study of Malaria (1909), W. B. Saunders Company, Philadelphia
64. Dobano C., Rogerson S.J., Taylor T.E., McBride J.S., and Molyneux M.E. Expression of merozoite surface protein markers by Plasmodium falciparum-infected erythrocytes in peripheral blood and tissues of children with fatal malaria. Infect. Immun. 75 (2007) 643-652
65. Dodgson C.L. Through the Looking-Glass (1872), Macmillan and Co, London
66. Dzikowski R., Templeton T.J., and Deitsch K. Variant antigen gene expression in malaria. Cell. Microbiol. 8 (2006) 1371-1381
67. Earle W.C., Perez M., del Rio J., and Arzola C. Observations on the course of naturally acquired malaria in Puerto Rico. Puerto Rican J. Public Health Trop. Med. 14 (1939) 391-406
68. Edeson J.F.B., and Field J.W. Proguanil-resistant falciparum malaria in Malaya. Br. Med. J. ii (1950) 147-151
69. Ehrman F.C., Ellis J.M., and Young M.D. Plasmodium vivax Chesson strain. Science 101 (1945) 377
70. Fairley N.H. Atebrin susceptibility of the Aitaipe-Wewak strains of P. falciparum and P. vivax. Trans. R. Soc. Trop. Med. Hyg. 40 (1946) 229-273
71. Ferreira M.U., and Hartl D.L. Plasmodium falciparum: Worldwide sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-2 (MSP-2). Exp. Parasitol. 115 (2007) 32-40
72. Ferreira M.U., Ribeiro W.L., Tonon A.P., Kawamoto F., and Rich S.M. Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum. Gene 304 (2003) 65-75
73. Fiertz C.O. The malarial treatment of general paralysis. State Hosp. Q. xi (1926) 626-643
74. Filipe J.A.N., Riley E.M., Drakeley C.J., Sutherland C.J., and Ghani1 A.C. Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput. Biol. 3 (2007) e255
75. Francis S.E., Malkov V.A., Oleinikov A.V., Rossnagle E., Wendler J.P., Mutabingwa T.K., Fried M., and Duffy P.E. Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum that infect pregnant women. Infect. Immun. 75 (2007) 4838-4850
76. Garnham P.C.C. Malaria Parasites and other Haemosporidia (1966), Blackwell Scientific Publications, Oxford
77. Gatton M.L., and Cheng Q. Modeling the development of acquired clinical immunity to Plasmodium falciparum malaria. Infect. Immun. 72 (2004) 6538-6545
78. Golgi C. On the cycle of development of malarial parasites in tertian fever: Differential diagnosis between the intracellular malarial parasites of tertian and quartan fever. In: Kean B.H., Mott K.E., and Russell A.J. (Eds). Tropical Medicine and Parasitology: Classic Investigations Volume I (1889), Cornell University Press, Ithaca, NY 26-35 1978
79. Grant A.R. The treatment of general paralysis by malaria. Br. Med. J. ii (1923) 698-700
80. Graves P.M., Carter R., and McNeill K.M. Gametocyte production in cloned lines of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33 (1984) 1045-1050
81. Graves P.M., Carter R., Keystone J.S., and Seeley Jr. D.C. Drug sensitivity and isoenzyme type in cloned lines of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33 (1984) 212-219
82. Gray J.C., Corran P.H., Mangia E., Gaunt M.W., Li Q., Tetteh K.K., Polley S.D., Conway D.J., Holder A.A., Bacarese-Hamilton T., Riley E.M., and Crisanti A. Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin. Chem. 53 (2007) 1244-1253
83. Gregson A., and Plowe C.V. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 57 (2005) 117-145
84. Gupta S., and Day K.P. A strain theory of malaria transmission. Parasitol. Today 10 (1994) 476-481
85. Gupta S., and Day K.P. A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria. Parasite Immunol. 16 (1994) 361-370
86. Gupta S., Snow R.W., Donnelly C.A., Marsh K., and Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 5 (1999) 340-343
87. Hackett L.W. Malaria in Europe (1937), Oxford University Press, London
88. Hackett L.W. Malaria and the community. In: Moulton F.R. (Ed). A Symposium on Human Malaria (1941), American Association for the Advancement of Science, Washington DC 148-156
89. Hankey D.D., Jones Jr. R., Coatney G.R., Alviing A.S., Coker W.G., Garrison P.L., and Donovan W.N. Korean vivax malaria. I. Am. J. Trop. Med. Hyg. 2 (1953) 958-969
90. Hastings I.M., and Donnelly M.J. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist. Updat. 8 (2005) 43-50
91. Hehir P. Malaria in India (1927), Oxford University Press, London
92. Hill E., and Amatuzio D.S. Southwest Pacific vivax malaria. Am. J. Trop. Med. 29 (1949) 203-214
93. Horing R.O. Induced and war malaria. J. Trop. Med. Hyg. 50 (1947) 150-160
94. Huber W., Haji H., Charlwood J.D., Certa U., Walliker D., and Tanner M. Genetic characterization of the malaria parasite Plasmodium falciparum in the transmission from the host to the vector. Parasitology 116 (1998) 95-101
95. Huff C.G. The significance of different strains of malaria and mosquitoes in the epidemiology of the disease. Am. J. Med. Technol. 4 (1938) 41-46
96. Imwong M., Snounou G., Pukrittayakamee S., Tanomsing N., Kim J.R., Nandy A., Guthmann J.P., Nosten F., Carlton J., Looareesuwan S., Nair S., Sudimack D., et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195 (2007) 927-933
97. James S.P. Malaria at Home and Abroad (1920), John Bale, Sons & Danielsson, Ltd., London
98. James S.P. Some general results of a study of induced malaria in England. Trans. R. Soc. Trop. Med. Hyg. 27 (1931) 477-538
99. James S.P., and Ciuca M. Species and races of human malaria parasites and a note on immunity. Acta Conventus Tertii de Tropicis Atque Malariae Morbis Volume 2 (1938), C. A. Spin & Zoon N. V., Amsterdam 269-281
100. James S.P., Nicol W.B., and Shute P.G. A study of induced malignant tertian malaria. Proc. R. Soc. Med. 25 (1932) 1153-1186
101. James S.P., Nicol W.B., and Shute P.G. Clinical and parasitological observations on induced malaria. Proc. R. Soc. Med. 29 (1936) 879-894
102. Jeffery G.M. Observations on a gametocyteless strain of Plasmodium falciparum. J. Natl. Malar. Soc. 10 (1951) 337-344
103. Jeffery G.M. Relapses with Chesson strain Plasmodium vivax following treatment with chloroquine. Am. J. Trop. Med. Hyg. 5 (1956) 1-13
104. Johnson S. A Dictionary of the English Language (1755), James Maxwell, London
105. Kaplan L.I., Read H.S., and Becker F.T. Homologous and heterologous strains of Plasmodium vivax: A cross-inoculation study of malaria strain immunity. J. Lab. Clin. Med. 31 (1946) 400-408
106. Kenrick W.H. Malaria in the Central Provinces. Proceedings of the Imperial Malaria Conference (1910), Government Central Branch Press, Simla 22-24
107. Kitchen S.F. Vivax malaria. In: Boyd M.F. (Ed). Malariology (1949), W. B. Saunders Company, Philadelphia 1027-1045
108. Kraemer S.M., and Smith J.D. A family affair: var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9 (2006) 374-380
109. Krotoski W.A., Collins W.E., Bray R.S., Garnham P.C., Cogswell F.B., Gwadz R.W., Killick-Kendrick R., Wolf R., Sinden R., Koontz L.C., and Stanfill P.S. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am. J. Trop. Med. Hyg. 31 (1982) 1291-1293
110. Kublin J.G., Cortese J.F., Njunju E.M., Mukadam R.A., Wirama J.J., Kazembe P.N., Djimde A.A., Kouriba B., Taylor T.E., and Plowe C.V. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187 (2003) 1870-1875
111. Kupper W.H. The Malarial Therapy of General Paralysis and Other Conditions." (1939), Edwards Brothers, Inc., Ann Arbor MI
112. Kyriacou H.M., Stone G.N., Challis R.J., Raza A., Lyke K.E., Thera M.A., Kone A.K., Doumbo O.K., Plowe C.V., and Rowe J.A. Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol. Biochem. Parasitol. 150 (2006) 211-218
113. Lambrechts L., Halbert J., Durand P., Gouagna L.C., and Koella J.C. Host genotype by parasite genotype interactions underlying the resistance of anopheline mosquitoes to Plasmodium falciparum. Malar. J. 11 (2005) 3
114. Laserson K.F., Petralanda I., Almera R., Barker Jr. R.H., Spielman A., Maguire J.H., and Wirth D.F. Genetic characterization of an epidemic of Plasmodium falciparum malaria among Yanomami Amerindians. J. Infect. Dis. 180 (1999) 2081-2085
115. Laveran A. Paludism (1893), The New Syndenham Society, London
116. League of Nations Health Organisation Malaria Commission. Ten years of activity of the Commission (1934) Geneva (document 212)
117. Leslie J.W.T. Malaria in India. In "Proceedings of the Imperial Malaria Conference" (1910), Government Central Branch Press, Simla 3-11
118. Lilly G.A. The treatment of general paralysis at Hanwell Mental Hospital. J. Ment. Sci. 71 (1925) 267-278
119. Lomholt M. Clinic and Prognosis of Malaria-Treated Paralysis (1944), Ejnar Munksgaard, Copenhagen
120. Macbride H.J. The treatment of general paralysis of the insane by malaria. J. Neurol. Psychopathol. 5 (1924) 13-27
121. Macdonald G. The Epidemiology and Control of Malaria (1957), Oxford University Press, London
122. Machado R.L., Povoa M.M., Calvosa V.S., Ferreira M.U., Rossit A.R., dos Santos E.J., and Conway D.J. Genetic structure of Plasmodium falciparum populations in the Brazilian Amazon region. J. Infect. Dis. 190 (2004) 1547-1555
123. Mackinnon M.J., and Read A.F. Selection for high and low virulence in the malaria parasite Plasmodium chabaudi. Proc. R. Soc. London Ser. B 266 (1999) 741-748
124. Mackinnon M.J., Gaffney D.J., and Read A.F. Virulence in rodent malaria: Host genotype by parasite genotype interactions. Infect. Genet. Evol. 1 (2002) 287-296
125. Marchiafava E., and Bignami A. On Summer-Autumn Malarial Fevers (1894), The New Syndenham Society, London
126. Marchoux E. Multiplicite des races dans les trois formes de parasites du paludisme. Bulletin de la Société de Pathologie Exotique 15 (1922) 108-109
127. McNamara J.V., Rieckmann K.H., Frischer H., Stockert T.A., Carson P.E., and Powell R.D. Acquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant Plasmodium falciparum. Ann. Trop. Med. Parasitol. 61 (1967) 386-395
128. Miller L.H., Mason S.J., Clyde D.F., and McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295 (1976) 302-304
129. Mita T., Kaneko A., Hwaihwanje I., Taukahara T., Takahashi N., Osawa H., Tanabe K., Kobayakawa T., and Bjorkman A. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolones in Papua New Guinea. Infect. Genet. Evol. 6 (2006) 447-452
130. Moore D.V., and Lanier J.E. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am. J. Trop. Med. Hyg. 10 (1961) 5-9
131. Napier L.E. The malaria relapse problem. J. Trop. Med. Hyg. 50 (1947) 147-150
132. Nocht B., and Mayer M. Malaria (1937), John Bale Medical Publications, London
133. Pearce R., Malisa A., Kachur S.P., Barnes K., Sharp B., and Roper C. Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum. Mol. Biol. Evol. 22 (2005) 1834-1844
134. Peyerl-Hoffmann G., Jelinek T., Kilian A., Kabagambe G., Metzger W.G., and von Sonnenburg F. Genetic diversity of Plasmodium falciparum and its relationship to parasite density in an area with different malaria endemicities in West Uganda. Trop. Med. Int. Health 6 (2001) 607-613
135. Pijper A., and Russell E.D. Malaria treatment of general paralysis: A report on 44 cases. S. Afr. Med.l Rec. 35 (1926) 292-305
136. Ramsdale C.D., and Coluzzi M. Studies on the infectivity of tropical African strains of Plasmodium falciparum to some southern European vectors of malaria. Parassitologia 17 (1975) 39-48
137. Ranford-Cartwright L.C., Balfe P., Carter R., and Walliker D. Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum. Parasitology 107 (1993) 11-18
138. Robertson G.I., Davey D.G., and Fairley N.H. Cross-resistance between "Daraprim" and Proguanil. Br. Med. J. ii (1952) 1255-1256
139. Rollo I.M., Williamson J., and Lourie E.M. Acquired paludrine-resistance in Plasmodium gallinaceum. II. Failure to produce such resistance by prolonged treatment of latent infections. Ann. Trop. Med. Parasitol. 42 (1948) 241-248
140. Rosario V. Cloning of naturally occurring mixed infections of malaria parasites. Science 212 (1981) 1037-1038
141. Ross R. The Prevention of Malaria (1910), E. P. Dutton & Company, New York
142. Russell P.F., West L.S., and Manwell R.D. Practical Malariology (1946), W. B. Saunders Company, Philadelphia
143. Salanti A., Dahlback M., Turner L., Nielsen M.A., Barfod L., Magistrado P., Jensen A.T., Lavstsen T., Ofori M.F., Marsh K., Hviid L., and Theander T.G. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200 (2004) 1197-1203
144. Sallenave-Sales S., Daubersies P., Mercereau-Puijalon O., Rahimalala L., Contamin H., Druilhe P., Daniel-Ribeiro C.T., and Ferreira-da-Cruz M.F. Plasmodium falciparum: A comparative analysis of the genetic diversity in malaria-mesoendemic areas of Brazil and Madagascar. Parasitol. Res. 86 (2000) 692-698
145. Sama W., Owusu-Agyei S., Felger I., Dietz K., and Smith T. Age and seasonal variation in the transition rates and detectability of Plasmodium falciparum malaria. Parasitology 132 (2006) 13-21
146. Schofield L., and Grau G.E. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5 (2005) 722-735
147. Schwartz R., Mansuy M.M., and John W.C. Current concepts on malaria. Arch. Intern. Med. 86 (1950) 837-856
148. Seaton D.R., and Adams A.R.D. Acquired resistance to proguanil in Plasmodium falciparum. Lancet ii (1949) 323-324
149. Seaton D.R., and Lourie E.M. Acquired resistance to proguanil (paludrine) in Plasmodium vivax. Lancet i (1949) 394-395
150. Sergent E., Parrot L., and Donatien A. Une question de terminologie, immuniser et premunir. Bulletin de la Société de Pathologie Exotique 17 (1924) 37-38
151. Sergent E., Parrot L., and Donatien A. On the necessity of having a term to express the resistance of carriers of germs to superimposed infections. Trans. R. Soc. Trop. Med. Hyg. 18 (1925) 383-385
152. Shortt H.E., and Garnham P.C.C. The pre-erythrocytic development of Plasmodium cynomolgi and Plasmodium vivax. Trans. R. Soc. Trop. Med. Hyg. 41 (1948) 785-795
153. Shortt H.E., Fairley N.H., Covell G., Shute P.G., and Garnham P.C.C. The pre-erythrocytic stage of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 44 (1951) 405-419
154. Shute P.G. Report on a third visit to Roumania for the Study of Malaria (1937), League of Nations Health Organisation Malaria Commission, Geneva (document 250)
155. Shute P.G. Failure to infect English specimens of Anopheles maculopennis var. atroparvus with certain strains of Plasmodium falciparum of tropical origin. J. Trop. Med. Hyg. 43 (1940) 175-178
156. Shute P.G. Latency and long-term relapses in benign tertian malaria. Trans. R. Soc. Trop. Med. Hyg. 40 (1946) 189-200
157. Shute P.G. Mosquito infection in artificially induced malaria. Br. Med. Bull. 8 (1951) 56-63
158. Shute P.G. Thirty years of malaria-therapy. J. Trop. Med. Hyg. 61 (1958) 557-561
159. Shute P.G., and Maryon M. A contribution to the problem of strains of human plasmodium. Riv. Malariol. 33 (1954) 1-21
160. Sinden R.E., Alavi Y., and Raine J.D. Mosquito-malaria interactions: A reappraisal of the concepts of susceptibility and refractoriness. Insect Biochem. Mol. Biol. 34 (2004) 625-629
161. Sinton J.A. Studies in malaria, with special reference to treatment. Part XV. Does the strain of parasite influence cure?. Indian J. Med. Res. 18 (1931) 845-853
162. Sinton J.A. A summary of our present knowledge of the mechanism of immunity in malaria. J. Malaria Inst. India 2 (1939) 71-83
163. Sinton J.A. Studies of infections with Plasmodium ovale. V. Trans. R. Soc. Trop. Med. Hyg. 33 (1940) 585-595
164. Smith F. Malaria: Immunity: Absence of negro immunity: Variety. Br. Med. J. ii (1898) 1807
165. Stephens J.W.W. A new malaria parasite of man. Ann. Trop. Med. Parasitol. 16 (1922) 383-388
166. Stratman-Thomas W.K. The infection in the intermediate host. Symptomatology: Vivax malaria. In: Moulton F.R. (Ed). A Symposium on Human Malaria (1941), American Association for the Advancement of Science, Washington DC 183-189
167. Thaithong S., Beale G.H., Fenton B., McBride J., Rosario V., Walker A., and Walliker D. Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 78 (1984) 242-245
168. Thomson J.G. The question of immunity in man to protozoal diseases. Proc. R. Soc. Med. 24 (1931) 499-513
169. Thomson J.G. Immunity in malaria. Trans. R. Soc. Trop. Med. Hyg. 26 (1933) 483-514
170. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
171. Trager W., Tershakovec M., Lyandvert L., Stanley H., Lanners N., and Gubert E. Clones of the malaria parasite Plasmodium falciparum obtained by microscopic selection: Their characterization with regard to knobs, chloroquine sensitivity, and formation of gametocytes. Proc. Natl. Acad. Sci. USA 78 (1981) 6527-6530
172. Viebig N.K., Gamain B., Scheidig C., Lepolard C., Przyborski J., Lanzer M., Gysin J., and Scherf A. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep. 6 (2005) 775-778
173. Vlachou D., and Kafatos F.C. The complex interplay between mosquito positive and negative regulators of Plasmodium development. Curr. Opin. Microbiol. 8 (2005) 415-421
174. Voller A. Comments on the detection of malaria antibodies. Am. J. Trop. Med. Hyg. 13 (1964) 204-208
175. Wagner-Jauregg J. The treatment of general paresis by inoculation of malaria. J. Nerv. Ment. Dis. 55 (1922) 369-375
176. Walliker D. The genetic basis of diversity in malaria parasites. Adv. Parasitol. 22 (1983) 217-259
177. Watson R.B. On the probability of soldiers with Pacific Plasmodium vivax malaria infecting Anopheles quadrimaculatus. J. Natl. Malar. Soc. 4 (1945) 183-188
178. Wellems T.E., and Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 184 (2001) 770-776
179. Wilson D.B. Rural hyper-endemic malaria in Tanganyika Territory. Trans. R. Soc. Trop. Med. Hyg. 29 (1936) 583-618
180. World Health Organization. Terminology of Malaria and of Malaria Eradication (1963) Geneva
181. World Health Organization. Parasitology of Malaria (1969) Technical Report 433. Geneva
182. World Health Organization. Malaria parasite strain characterization, cryopreservation, and banking of isolates: A WHO memorandum. Bull. World Health Organ. 59 (1981) 537-548
183. Yorke W., and Macfie J.W.S. Observations on malaria made during treatment of general paralysis. Trans. R. Soc. Trop. Med. Hyg. 18 (1924) 13-33
184. Young M.D. Studies on the periodicity of induced Plasmodium vivax. J. Natl. Malar. Soc. 3 (1944) 237-240
185. Young M.D., and Burgess R.W. Studies on imported malarias 9. The comparative susceptibility of Anopheles quadrimaculatus and Anopheles maculopennis freeborni to foreign vivax malarias. J. Natl. Malar. Soc. 7 (1948) 134-137
186. Young M.D., Ellis J.M., and Stubbs T.H. Some characteristics of foreign vivax malaria induced in neurosyphilis patients. Am. J. Trop. Med. 27 (1947) 585-596
187. Young M.D., Eyles D.E., and Burgess R.W. Studies on imported malarias. 10. An evaluation of the foreign malarias introduced into the United States by returning troops. J. Natl. Malar. Soc. 7 (1949) 171-185
188. Young M.D., Contacos P.G., Stitcher J.E., and Millar J.W. Drug resistance in Plasmodium falciparum from Thailand. Am. J. Trop. Med. Hyg. 12 (1963) 305-314
189. Yount Jr. E.H., and Coggeshall L.T. Status of immunity following cure of recurrent vivax malaria. Am. J. Trop. Med. Hyg. 29 (1949) 701-705
190. Zuckerman A. The antigenic analysis of plasmodia. Am. J. Trop. Med. Hyg. 13 (1964) 209-213